Mutaflor (Escherichia Coli Strain Nissle 1917)

The strain Nissle 1917 colonises the intestinal lining, where it competes with harmful bacteria for attachment sites, produces substances that inhibit pathogens, and interacts with the immune system to promote a balanced microbial environment and strengthen the gut barrier.

The dosage of Mutaflor is determined by the prescribing healthcare professional based on the patient’s condition, age, and clinical response. Patients should follow the specific instructions provided by their prescriber and not alter the regimen without medical advice.

Safety data for Mutaflor in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting the product.

To order Mutaflor, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mutaflor contains a single, well‑studied strain (E. coli Nissle 1917) with documented efficacy in ulcerative colitis, whereas many other probiotics are multi‑strain blends with broader but less specific evidence. The choice depends on the clinical indication, regulatory status and physician preference.

Mutaflor should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture. It does not require refrigeration, but exposure to high heat or humidity may reduce bacterial viability.

Mutaflor is taken orally, usually as a capsule or sachet containing live bacteria. It should be swallowed with water according to the prescriber’s instructions, and may be taken with or without food depending on individual tolerance.

The most serious risks include rare cases of systemic infection such as sepsis or bacteremia, particularly in patients with severely compromised immune systems. Prompt medical attention is required if signs of infection, such as fever or chills, develop.

Mutaflor is contraindicated in individuals with known hypersensitivity to the product and should be avoided in patients with severe immunosuppression or those at high risk for invasive bacterial infections unless specifically advised by a healthcare professional.